Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery

BACKGROUND: Levosimendan a calcium ion sensitizer improves both systolic and diastolic functions. This novel lusitropic drug has predictable antiischemic properties which are mediated via the opening of mitochondrial adenosine triphosphate-sensitive potassium channels. This action of levosimendan is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Manoj K., Das, Anupam, Malik, Vishwas, Subramanian, Arun, Singh, Sarvesh Pal, Hote, Milind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900377/
https://www.ncbi.nlm.nih.gov/pubmed/26750674
http://dx.doi.org/10.4103/0971-9784.173020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900377/
https://www.ncbi.nlm.nih.gov/pubmed/26750674
http://dx.doi.org/10.4103/0971-9784.173020

Ejemplares similares